Gravitas Medical Inc. Announces SECOND FDA Breakthrough Device Designation for its Entarik System; Pediatric Patients to Benefit from Enteral Nutrition Innovation!
/
DateDec 13 2023
Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik’s revolutionary technology. SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ — Gravitas... Read More →